The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies.
 
Jacob Drobnyk Soumerai
No Relationships to Disclose
 
Jacqueline Claudia Barrientos
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen
Research Funding - Abbvie; Gilead Sciences; Pharmacyclics
 
Michael Hallek
Speakers' Bureau - Mundipharma; Roche
Research Funding - Celgene; Gilead Sciences; Janssen; Mundipharma; Roche
 
Thomas J. Kipps
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Genentech; Gilead Sciences; Pharmacyclics
 
Jeffrey Alan Jones
Consulting or Advisory Role - Genentech/Abbvie; Gilead Sciences; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Janssen (Inst); MedImmune (Inst); Pharmacyclics (Inst)
 
Stephan Stilgenbauer
Honoraria - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Research Funding - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
Travel, Accommodations, Expenses - Abbvie; Amgen; Boehringer Ingelheim; Celgene; Genentech; Genzyme; Gilead Sciences; GlaxoSmithKline; Janssen; Mundipharma; Novartis; Pharmacyclics; Roche; Sanofi
 
Guan Xing
Employment - Gilead Sciences
 
Nai-Shun Yao
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences; GlaxoSmithKline
 
Loic Ysebaert
Research Funding - Celgene
 
Andrew David Zelenetz
No Relationships to Disclose